The Public Health Challenge of Δ 8 -THC and Derived Psychoactive Cannabis Products
JAMA · 12.03.2024 · 331 (10) · 834
DOI: 10.1001/jama.2024.0801 ↗Kurz gefasst
Editorial in der Zeitschrift JAMA, erschienen am 12.03.2024. Verfasst von Jennifer M Whitehill und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst. Hauptthemen laut MEDLINE: Cannabis, Public Health, Dronabinol, Psychotropic Drugs. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst.
- Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
- Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Zitieren
APA
Whitehill, J. M., Dunn, K. E., & Johnson, R. M. (2024). The Public Health Challenge of Δ 8 -THC and Derived Psychoactive Cannabis Products. JAMA, 331(10), 834. https://doi.org/10.1001/jama.2024.0801
Vancouver
Whitehill JM, Dunn KE, Johnson RM. The Public Health Challenge of Δ 8 -THC and Derived Psychoactive Cannabis Products. JAMA. 2024;331(10):834. doi:10.1001/jama.2024.0801
BibTeX
@article{Whitehill2024,
author = {Whitehill, Jennifer M and Dunn, Kelly E and Johnson, Renee M},
title = {The Public Health Challenge of Δ 8 -THC and Derived Psychoactive Cannabis Products},
journal = {JAMA},
year = {2024},
volume = {331},
number = {10},
pages = {834},
doi = {10.1001/jama.2024.0801}
}
EUVIMED